Fairfield, Bush & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $958K | Sell |
1,950
-40
| -2% | -$21.7K | 0.53% | 50 |
|
|
2025
Q4 | $1.15M | Sell |
1,990
-78
| -4% | -$44.1K | 0.61% | 42 |
|
|
2025
Q3 | $1M | Buy |
2,068
+264
| +15% | +$123K | 0.52% | 48 |
|
|
2025
Q2 | $731K | Buy |
1,804
+150
| +9% | +$62.7K | 0.41% | 60 |
|
|
2025
Q1 | $823K | Buy |
1,654
+105
| +7% | +$56.9K | 0.52% | 54 |
|
|
2024
Q4 | $806K | Sell |
1,549
-920
| -37% | -$506K | 0.47% | 57 |
|
|
2024
Q3 | $1.53M | Sell |
2,469
-657
| -21% | -$389K | 0.91% | 35 |
|
|
2024
Q2 | $1.73M | Sell |
3,126
-130
| -4% | -$74.5K | 1.04% | 30 |
|
|
2024
Q1 | $1.89M | Sell |
3,256
-435
| -12% | -$244K | 1.12% | 27 |
|
|
2023
Q4 | $1.96M | Sell |
3,691
-118
| -3% | -$57.1K | 1.15% | 24 |
|
|
2023
Q3 | $1.93M | Sell |
3,809
-517
| -12% | -$275K | 1.26% | 24 |
|
|
2023
Q2 | $2.26M | Buy |
4,326
+96
| +2% | +$51.8K | 0.62% | 37 |
|
|
2023
Q1 | $2.44M | Buy |
4,230
+595
| +16% | +$335K | 0.86% | 33 |
|
|
2022
Q4 | $2M | Buy |
3,635
+331
| +10% | +$175K | 1.32% | 23 |
|
|
2022
Q3 | $1.68M | Buy |
3,304
+256
| +8% | +$143K | 1.18% | 25 |
|
|
2022
Q2 | $1.66M | Buy |
3,048
+120
| +4% | +$66.1K | 0.97% | 27 |
|
|
2022
Q1 | $1.73M | Buy |
2,928
+36
| +1% | +$20.7K | 0.87% | 30 |
|
|
2021
Q4 | $1.93M | Sell |
2,892
-630
| -18% | -$393K | 0.93% | 27 |
|
|
2021
Q3 | $2.01M | Sell |
3,522
-600
| -15% | -$329K | 0.65% | 41 |
|
|
2021
Q2 | $2.08M | Buy |
4,122
+117
| +3% | +$55.2K | 0.57% | 42 |
|
|
2021
Q1 | $1.83M | Buy |
4,005
+830
| +26% | +$396K | 0.52% | 44 |
|
|
2020
Q4 | $1.48M | Buy |
3,175
+475
| +18% | +$223K | 0.43% | 52 |
|
|
2020
Q3 | $1.19M | Sell |
2,700
-265
| -9% | -$109K | 0.38% | 58 |
|
|
2020
Q2 | $1.07M | Buy |
2,965
+740
| +33% | +$248K | 0.38% | 60 |
|
|
2020
Q1 | $631K | Buy |
2,225
+1,225
| +123% | +$386K | 0.26% | 73 |
|
|
2019
Q4 | $325K | Hold |
1,000
| – | – | 0.12% | 113 |
|
|
2019
Q3 | $291K | Hold |
1,000
| – | – | 0.1% | 121 |
|
|
2019
Q2 | $294K | Hold |
1,000
| – | – | 0.1% | 121 |
|
|
2019
Q1 | $274K | Hold |
1,000
| – | – | 0.09% | 128 |
|
|
2018
Q4 | $224K | Hold |
1,000
| – | – | 0.08% | 137 |
|
|
2018
Q3 | $244K | Hold |
1,000
| – | – | 0.07% | 143 |
|
|
2018
Q2 | $207K | Hold |
1,000
| – | – | 0.06% | 152 |
|
|
2018
Q1 | $206K | Buy |
+1,000
| New | +$210K | 0.06% | 150 |
|
Other funds holding TMO
VCM
Fairfield, Bush & Co's TMO Position: Q1 2026 in Review
Fairfield, Bush & Co reduced its Thermo Fisher Scientific (TMO) stake by 2% in Q1 2026, selling an estimated $21.7K and leaving 1,950 shares worth $958K. The position accounts for 0.53% of the portfolio, ranked #50.
Fairfield, Bush & Co first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $2.44M in Q1 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Fairfield, Bush & Co held 1,950 shares of Thermo Fisher Scientific worth $958K as of Q1 2026.
- Fairfield, Bush & Co sold 40 Thermo Fisher Scientific shares in Q1 2026, an estimated $21.7K.
- Thermo Fisher Scientific made up 0.53% of Fairfield, Bush & Co's portfolio in Q1 2026, its #50 holding.
- Fairfield, Bush & Co first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Fairfield, Bush & Co's Thermo Fisher Scientific position peaked at $2.44M in Q1 2023.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.